Maintenance of Physical Activity After Cardiac Rehabilitation (FAIR)

April 6, 2022 updated by: Slagelse Hospital

Maintenance of Physical Activity After Cardiac Rehabilitation: a Feasibility Trial

Physical activity is a key element in cardiac rehabilitation and prevention of cardiovascular mortality and hospitalizations. After cardiac rehabilitation programs end, physical activity levels and participation in continued cardiac rehabilitation declines. The aim of this study is to evaluate the feasibility a mobile health intervention with text messages and behavior change theory in patients with cardiovascular disease for a duration of 3 months after completion of a cardiac rehabilitation program. An intervention consisting of action planning, text messages, and coordinator support is tested in a feasibility trial design with 40 expected participants.

Study Overview

Detailed Description

Physical activity is a key element in cardiac rehabilitation and prevention of cardiovascular mortality and hospitalizations. After cardiac rehabilitation programs end, physical activity levels and participation in continued cardiac rehabilitation declines.

The primary aim of this study is to evaluate the feasibility in terms of recruitment, retention, data completeness, intervention delivery and compliance, and acceptability of a mobile health intervention with text messages and behavior change theory in patients with cardiovascular disease for a duration of 3 months after completion of a cardiac rehabilitation program.

The study is a single-group multi-site feasibility trial. Participants will be recruited from phase II cardiac rehabilitation programs at Slagelse Hospital, the city of Slagelse (municipality), and Holbæk Hospital. Starting immediately after completion of cardiac rehabilitation, study participants will receive an intervention that consists of action planning, text messages, and coordinator support for a period of 12 weeks (see more details under 'Arms and Interventions'). The investigators base the intervention on a theoretical model of behavior change in the form of the Health Action Process Approach (HAPA). Behavior change techniques (BCTs) are used as part of the intervention. The intervention is an addition to standard practice and does not replace any existing treatment offers.

To evaluate the feasibility of the intervention and its readiness to be tested in a subsequent RCT design, the investigators have set progression criteria using a system of green (proceed to RCT), amber (amend when proceeding to RCT), or red (issue must be solved before proceeding to RCT). The progression criteria are listed under 'Primary Outcome Measures'.

Participants will wear accelerometers on thigh and wrist for 1 and 3 weeks, respectively, starting 1 week before end of cardiac rehabilitation. Baseline measurements and start of intervention is planned to be at the same time as cardiac rehabilitation ends. After 11 weeks of intervention, participants will attend a follow-up assessment, where participants will wear accelerometers on thigh and wrist again.

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Holbæk, Denmark, 4300
        • Recruiting
        • Holbæk Hospital
      • Korsør, Denmark, 4220
        • Recruiting
        • City of Slagelse (municipality)
      • Slagelse, Denmark, 4200
        • Recruiting
        • Slagelse Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age ≥18 years.
  • Participant in an exercise-based cardiac rehabilitation program in either hospital or municipality setting.
  • Access to a personal mobile phone and Danish telephone number.
  • Able to walk 3 meters without assistance.

Exclusion Criteria:

  • Insufficient Danish language proficiency to read and understand text messages and questionnaires.
  • Patients cognitively or mentally unable to participate.
  • Terminal patients and patients with a life expectancy of less than 3 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Maintenance intervention
Participants will receive a 12-week mobile health (mHealth) intervention that consists of action planning, text messages, and coordinator support.

The intervention consists of action planning, text messages, and coordinator support.

At onset, each participant creates an action plan for physical activity with the help of a health professional:

  • What types of physical activities?
  • When and how often?
  • Where and with who?

    2 auto-generated text messages are sent weekly for a duration of 12 weeks. The first prompts physical activity. The second asks if plans were reached. If yes, an automatic reply with positive reinforcement is generated. If no, an automatic reply asks if the participant wants to be contacted.

Participants are contacted by a coordinator either by answering text messages or if not answering the texts for a period of 2 weeks or more. Coordinator functions:

  • Call participants replying to texts that they wish to be contacted
  • Help participants establish contact to local activities involving physical activity
  • Follow-up on and adjustment of action plan
  • Offer guidance in physical activity

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recruitment
Time Frame: Baseline

Green: Mean of ≥0.75 recruited participants per week per site

Amber: Mean of 0.5-0.74 recruited participants per week per site

Red: Mean of <0.5 recruited participants per week per site

Baseline
Attrition/retention through follow-up assessment session
Time Frame: Up to 12 weeks

Green: ≥80% retention of participants through follow up

Amber: 50-79% retention of participants through follow up

Red: <50% retention of participants through follow up

Up to 12 weeks
Accelerometer data completeness
Time Frame: Baseline

Green: Accelerometer data from both baseline and follow-up available on ≥80% of completing participants

Amber: Data available on 50-79% of completing participants

Red: Data available on <50% of completing participants

Baseline
Accelerometer data completeness
Time Frame: 12 weeks

Green: Accelerometer data from both baseline and follow-up available on ≥80% of completing participants

Amber: Data available on 50-79% of completing participants

Red: Data available on <50% of completing participants

12 weeks
Response rate on patient reported outcomes
Time Frame: Baseline

Green: ≥90% of participants attending baseline and follow-up assessment return patient reported outcomes

Amber: 75-89% of patients attending baseline and follow-up assessment return patient reported outcomes

Red: <75% of participants attending baseline and follow-up assessment return patient reported outcomes

Baseline
Response rate on patient reported outcomes
Time Frame: 12 weeks

Green: ≥90% of participants attending baseline and follow-up assessment return patient reported outcomes

Amber: 75-89% of patients attending baseline and follow-up assessment return patient reported outcomes

Red: <75% of participants attending baseline and follow-up assessment return patient reported outcomes

12 weeks
Coordinator time spent, minutes per participant throughout the intervention
Time Frame: 12 weeks

Green: Mean coordinator time spent of ≤30 minutes per participant

Amber: Mean coordinator time spent of 31-60 minutes per participant

Red: Mean coordinator time spent of >60 minutes per participant

12 weeks
Response rate (adherence) to weekly follow-up messages
Time Frame: 12 weeks

Green: ≥75% of patients respond to at least 75% of messages

Amber: 50-74% of patients respond to at least 75% of messages

Red: <50% of patients respond to at least 75% of messages

12 weeks
Acceptability of text message component, single item
Time Frame: 12 weeks

Green: ≥75% of participants find text messages acceptable

Amber: 50-74% of participants find text messages acceptable

Red: <50% of participants find text messages acceptable

12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical activity, objectively measured
Time Frame: Change from baseline to 12 weeks
Measured with thigh and wrist accelerometers
Change from baseline to 12 weeks
Physical function, walking
Time Frame: Change from baseline to 12 weeks
6 minute walking test
Change from baseline to 12 weeks
Physical function, sit-to-stand
Time Frame: Change from baseline to 12 weeks
30-second sit-to-stand test
Change from baseline to 12 weeks
Physical activity, subjectively measured
Time Frame: Change from baseline to 12 weeks
The International Physical Activity Questionnaire (IPAQ) is used to measure physical activity in the past 7 days. 0 is minimum (completely inactivty).
Change from baseline to 12 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health-related quality of life, general
Time Frame: Change from baseline to 12 weeks
EQ-5D-5L evaluates health status in 5 dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension is rated from 1 (best) to 5 (worst) and overall health is rated on a 0 to 100 VAS scale.
Change from baseline to 12 weeks
Health-related quality of life, VAS subscale
Time Frame: Change from baseline to 12 weeks
EQ-5D-5L evaluates health status in 5 dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension is rated from 1 (best) to 5 (worst) and overall health is rated on a 0 to 100 VAS scale.
Change from baseline to 12 weeks
Health-related quality of life, heart-specific
Time Frame: Change from baseline to 12 weeks
HeartQoL is used to measure heart-specific quality of life in the past 4 weeks. Range from 0 (worst) to 42 (best) .
Change from baseline to 12 weeks
Anxiety and depression
Time Frame: Change from baseline to 12 weeks
Hospital Anxiety and Depression Scale (HADS). HADS gives a score for each of anxiety and depression, each ranging from 0 (best) to 21 (worst).
Change from baseline to 12 weeks
Physical function, self-reported
Time Frame: Change from baseline to 12 weeks
WHO Disability Assessment Schedule 2.0 (WHODAS 2.0),12-item version. WHODAS is a generic assessment instrument for health and disability. Range from 12 (no disability) to 60 (highest disability or loss of function).
Change from baseline to 12 weeks
Comorbidity
Time Frame: Change from baseline to 12 weeks
Disease Burden: Morbidity Assessment by Self-Report used to evaluated a list of common chronic conditions affect the participants' daily activities. Each condition (that the participant has) is rated from 1 (not at all) to 5 (a lot) in regard to how much it limits daily activities.
Change from baseline to 12 weeks
Self-efficacy, managing chronic disease
Time Frame: Change from baseline to 12 weeks
Self-efficacy of managing chronic disease 6 items scale. Score is calculated as the mean of 6 items, each scored from 1 (low self-efficacy) to 10 (high self-efficacy).
Change from baseline to 12 weeks
Motivational Self-efficacy
Time Frame: Change from baseline to 12 weeks
Motivational self-efficacy, HAPA items by Schwartzer R., 2 items each rated on a scale from 1 (low self-efficacy) to 4 (high self-efficacy).
Change from baseline to 12 weeks
Coping Self-efficacy
Time Frame: Change from baseline to 12 weeks
Coping self-efficacy, HAPA items by Schwartzer R., 2 items each rated on a scale from 1 (low self-efficacy) to 4 (high self-efficacy).
Change from baseline to 12 weeks
Recovery Self-efficacy
Time Frame: Change from baseline to 12 weeks
Recovery self-efficacy, HAPA items by Schwartzer R., 2 items each rated on a scale from 1 (low self-efficacy) to 4 (high self-efficacy).
Change from baseline to 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rune M Andersen, PhD, Næstved-Slagelse-Ringsted Hospitals; University of Southern Denmark
  • Study Chair: Lars H Tang, PhD, Næstved-Slagelse-Ringsted Hospitals; University of Southern Denmark
  • Study Chair: Søren T Skou, PhD, Næstved-Slagelse-Ringsted Hospitals; University of Southern Denmark

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 30, 2021

Primary Completion (Anticipated)

April 30, 2022

Study Completion (Anticipated)

April 30, 2022

Study Registration Dates

First Submitted

July 17, 2021

First Submitted That Met QC Criteria

August 17, 2021

First Posted (Actual)

August 19, 2021

Study Record Updates

Last Update Posted (Actual)

April 14, 2022

Last Update Submitted That Met QC Criteria

April 6, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • EMN-2021-00020 (Other Identifier: Research Ethics Committee of Region Zealand, Denmark)
  • REG-162-2020 (Other Identifier: Danish Data Protection Agency through Region Zealand)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myocardial Ischemia

Clinical Trials on Maintenance intervention

3
Subscribe